[Intensive care of children with DIC syndrome based on the use of low molecular weight heparins].
The first section of this paper presents data on low-molecular-weight heparins: pharmacokinetics and pharmacodynamics, advantages in comparison with common heparin. The second section presents the results of fraxiparin and clivarin use in 43 children aged 9 months to 14 years with acute/subacute DIC syndrome of infectious origin. Therapeutic and maintenance doses, the mode of injection of low-molecular-weight heparins, and methods for laboratory monitoring of their efficiency and safety are presented.
Chuprova
A V
AV
Shmakov
A N
AN
Solov'ev
O N
ON
Anokhina
T Iu
TIu
Loskutova
S A
SA
Pinegina
Iu S
IuS
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male
D006495:Heparin, Low-Molecular-Weight